The UK government's Industrial Strategy sets out an ambition for the country to 'be the world's most innovative economy' and play a leading role in a 'fourth industrial revolution... characterised by a fusion of technologies that is blurring the lines between the physical, digital and biological worlds'.
The first in a series of Sector Deals published by the government describes how 'a new genomics industry is beginning to emerge', and discusses investments from and agreements with a variety of companies involving the whole genomes of around 70,000 participants in the 100,000 Genomes Project and around half a million participants in UK Biobank.
This podcast, produced by Pod Academy, documents a debate on this subject entitled 'Putting Your Genome to Work: For the NHS, for Industry, for the UK Post-Brexit'. The debate was organised by the Progress Educational Trust (PET), the charity that publishes BioNews, and was supported by the Medical Research Council.
The discussion is chaired by Sarah Norcross (director of PET) and includes presentations from Dr Eliot Forster (chair of MedCity), Dr Athena Matakidou (head of clinical genomics at AstraZeneca's Centre for Genomics Research), Dr Edward Hockings (founding director of Ethics and Genetics) and Dr Jayne Spink (chief executive of Genetic Alliance UK).
Listen to the podcast using the player below.
|00:00||Tess Woodcraft: Introduction from Pod Academy|
|00:42||Sarah Norcross: Introduction from the chair|
|03:02||Dr Eliot Forster: An industrial strategy perspective|
|09:47||Dr Athena Matakidou: A pharmaceutical industry perspective|
|16:50||Dr Edward Hockings: A critical perspective|
|26:09||Dr Jayne Spink: A patient advocacy perspective|
|35:37||Sarah Norcross: Close from the chair|